Chronic Kidney Disease (CKD)

• BC renal guidelines http://www.bcrenal.ca/ 

• Renal Dosage Adjustment Resource: https://kdpnet.kdp.louisville.edu/drugbook/adult/?leaf=4726

• 2024 Kdigo guidelines: https://kdigo.org/wp-content/uploads/2017/02/KDIGO-2024-CKD-Guideline-Executive-Summary.pdf

1. According to KDIGO, how long must markers of kidney damage or reduced eGFR be present to define CKD?

a) ≥ 3 months

b) ≥ 2 months

c) ≥ 1 month

d) ≥ 6 months

2. Which of the following is NOT a marker of kidney damage in CKD? 

a) Urine sediment abnormalities

b) Increased eGFR

c) Structural abnormalities by imaging

d) Abnormal histology

3. At what stage do complications of CKD, such as abnormal mineral metabolism and anemia, typically begin?

a) Stage 2

b) Stage 3a

c) Stage 4

d) Stage 3b

4. What are common extrarenal symptoms of CKD?

a) Hematuria, frothy urine, flank pain

b) Hypertension, edema, uremic symptoms

c) Flank pain, fever, hematuria

d) Elevated SCr, reduced GFR, elevated ACR

5. Which of the following is NOT a renoprotective agent used to slow CKD progression?

a) ACE inhibitors

b) ARBs

c) NSAIDs

d) SGLT2 inhibitors